Chapter 3: The Digestive Effects You Should Know About
Because semaglutide affects the digestive system, gastrointestinal symptoms are among the most commonly reported effects.
Nausea is particularly common when treatment is first started or when the dose is increased.
For many people, nausea becomes less noticeable as their body adapts. Eating smaller meals, avoiding foods that trigger symptoms, and staying appropriately hydrated may help, although anyone experiencing significant or persistent symptoms should discuss them with their healthcare professional.
Vomiting and diarrhea can also occur.
These symptoms are especially important when they become severe because repeated vomiting or diarrhea can cause dehydration.
Dehydration can lead to dizziness, weakness, headaches, reduced urination, and other problems. People who are unable to keep fluids down may need medical attention.
Constipation is another possible side effect.
Because appetite may decrease, a person may consume substantially less food and fiber than before. Reduced fluid intake and lower physical activity can further contribute to constipation.
Abdominal discomfort and bloating may also occur.
However, not every type of abdominal pain should simply be attributed to the medication.
Severe or persistent abdominal pain requires medical evaluation because semaglutide is associated with important warnings, including the possibility of acute pancreatitis. Pancreatitis can cause severe abdominal pain that may radiate toward the back and may be accompanied by vomiting.
Another important concern involves the gallbladder.
Gallbladder problems, including gallstones and inflammation of the gallbladder, have been reported in people using semaglutide. Rapid weight loss itself can also increase the risk of gallstones.
Symptoms such as persistent upper abdominal pain, fever, jaundice, or significant vomiting should therefore not be ignored.
There is also an important prescribing consideration for people with certain gastrointestinal conditions. Because semaglutide delays gastric emptying, it may not be appropriate for everyone, particularly people with certain severe gastrointestinal disorders.
Anyone scheduled for a procedure requiring anesthesia or deep sedation should tell their medical team that they are taking semaglutide. Healthcare professionals can determine whether special instructions are necessary.
The takeaway is not that Ozempic is inherently dangerous.
Rather, it is that a medication that produces meaningful physiological effects should be used with appropriate medical oversight.
Common digestive symptoms may improve with time, but severe, persistent, or unusual symptoms should be evaluated instead of automatically being considered a normal part of treatment.